 Receptor, Angiotensin, Type 2
"Receptor, Angiotensin, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.
| Descriptor ID |
D044139
|
| MeSH Number(s) |
D12.776.543.750.100.047.687 D12.776.543.750.720.600.150.687 D12.776.543.750.750.130.875 D12.776.543.750.750.555.150.875
|
| Concept/Terms |
Receptor, Angiotensin, Type 2- Receptor, Angiotensin, Type 2
- Angiotensin II Type 2 Receptor
- Receptor, Angiotensin II Type 2
- Angiotensin AT2 Receptor
- AT2 Receptor, Angiotensin
- Receptor, Angiotensin AT2
- Angiotensin Type 2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Angiotensin, Type 2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Angiotensin [D12.776.543.750.100.047]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.100.047.687]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Angiotensin [D12.776.543.750.720.600.150]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.720.600.150.687]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Angiotensin [D12.776.543.750.750.130]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.750.130.875]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Angiotensin [D12.776.543.750.750.555.150]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.750.555.150.875]
Below are MeSH descriptors whose meaning is more specific than "Receptor, Angiotensin, Type 2".
This graph shows the total number of publications written about "Receptor, Angiotensin, Type 2" by people in UAMS Profiles by year, and whether "Receptor, Angiotensin, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2013 | 0 | 1 | 1 | | 2012 | 2 | 0 | 2 | | 2011 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2004 | 0 | 1 | 1 | | 2001 | 0 | 2 | 2 | | 1998 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor, Angiotensin, Type 2" by people in Profiles over the past ten years.
-
Fouda AY, Ahmed HA, Pillai B, Kozak A, Hardigan T, Ergul A, Fagan SC, Ishrat T. Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochem Int. 2022 09; 158:105375.
-
Eldahshan W, Ishrat T, Pillai B, Sayed MA, Alwhaibi A, Fouda AY, Ergul A, Fagan SC. Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. Am J Physiol Heart Circ Physiol. 2019 05 01; 316(5):H1192-H1201.
-
Fouda AY, Pillai B, Dhandapani KM, Ergul A, Fagan SC. Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. Eur J Pharmacol. 2017 Mar 15; 799:128-134.
-
Alhusban A, Fouda AY, Ishrat T, Soliman S, Fagan SC. Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. J Hypertens. 2015 Jan; 33(1):170-80.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|